Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Siveele
Breda, North Brabant, Netherlands
- Ownership
- Private
- Employees
- ~209
- Development stage
- Other
01
Overview
Siveele's natural antimicrobials—Nisin (Niseen-S), Natamycin (Nataseen-L), and ε-Polylysine—are commercially available and used to prevent spoilage and fungal/microbial contamination, widely adopted globally across food, feed, pharmaceutical, and personal healthcare industries
- Therapeutic areas
- Infectious DiseasesOther
- Modalities
- ProteinLive biotherapeutic product therapy
- Industry
- Non-Drug Biotech
02
Partnerships
Silver Elephant (long-term cooperation on production line since 1994)
Beyond the preview
Go deeper on Siveele.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Siveele.